MedTrace Logo

Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

NCT07087145 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2025-08-01

No results posted yet for this study

Summary

People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race/ethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding the racial/ethnic differences in oral HPV infection, persistence of oral HPV infection, or progression of oral HPV infection to OPC among PLWH. This is an observational, prospective cohort study to investigate the feasibility of alternative sample collection methods for HPV testing among PLWH.

Conditions

Interventions

DIAGNOSTIC_TEST

Mail-based Saliva Sample Kit

Sent via United States Postal Service and returned via FedEx

OTHER

Study-related Surveys

Online surveys will be administered

Sponsors & Collaborators

Principal Investigators

  • Alexandra Hernandez Levenston, MD, MPH · University of California, San Francisco

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-17
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07087145 on ClinicalTrials.gov